Monday, April 22, 2024

New Breakthrough in Hair loss Technology : Minoxidil Response DNA Test (MRT) by TrichoGene,

Published on


Hair loss, whether it is hair loss in men or hair loss in women, is a common biological problem all over the world, not just in India. The importance of hair in enhancing the overall personality of a human being cannot be overestimated.

Hair loss, on the other hand, can prove to be a real disadvantage for many people. Many young boys and girls start losing their hair early in life. Caused by a variety of genetic, environmental, and systemic factors, hair fall can affect everyone, regardless of their country of origin. Thankfully, effective hair treatment can control and even reverse the hair loss process. Minoxidil – the only FDA approved topical hair regrowth treatment for genetic hair loss in men and women. Unknown until now, you need an enzyme present (SULT1A1) to convert Minoxidil to its active form to regrow hair for genetic hair loss – the worldwide leading cause of hair loss in both men and women. If you lack the enzyme, Minoxidil will not work for you. Through meticulous research and persistence, Hyderabad based startup company TrichoGene – DNA based hair treatment with their innovative idea discovered the need for the SULT1A1 enzyme for hair regrowth success with topical Minoxidil. 

“We have seen the frustration and emotional toll of losing one’s hair,” shares Founders, Dr.M.Sai Babu and Rizwan Younus. We have spent most of our time to finding solutions to hair loss. The Minoxidil Response Test is the biggest development to hit the hair loss category as it will help men and women immediately determine the best course of action to treat their hair loss – no need to waste time, money or false hope on a treatment that biologically does not work for you.”

The Minoxidil Response Test (MRT) for men and for women is a simple, non-invasive, at-home buccal swab DNA test. Samples are sent to TrichoGene and processed in ICMR, DSIR and NABL certified  Lab and evaluated SULT1A1*2 gene polymorphism for the presence of the SULT1A1 enzyme using advanced genomics technology. Results are secured in a HIPPA-compliant server and reported back to the customer in their personal Trichogene account. From there, the customer can work directly with their healthcare provider on the next steps to treat their hair loss. 

“We are set on a course to forever change the way we approach and treat genetic hair loss,” said Founders Dr.M. sai Babu and Rizwan Younus. “MRT is just one of many exciting new diagnostic hair loss tests that will be made available to consumers from Trichogene. All will offer discreetness and convenience, made for use in the privacy of home to help gain control over hair loss and seek the best solutions based on one’s genetics and personal response mechanisms.”

Latest articles